Currency in SEK
| Earnings estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 0.98 | 1.06 | 4.08 | 4.43 |
| Low estimate | 0.97 | 1.03 | 3.99 | 4.41 |
| High estimate | 1 | 1.1 | 4.18 | 4.45 |
| Year ago EPS | 0.8 | 1.01 | 3.62 | 4.08 |
| Revenue estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 357.55M | 346.05M | 1.44B | 1.61B |
| Low estimate | 353M | 337.1M | 1.43B | 1.6B |
| High estimate | 362.1M | 355M | 1.44B | 1.61B |
| Year ago sales | 315.22M | 317.69M | 1.3B | 1.44B |
| Sales growth (year/est) | 13.40% | 8.90% | 10.90% | 11.80% |
| Earnings history | 30/06/2023 | 30/09/2023 | 31/12/2023 | 31/03/2024 |
|---|
| Est. EPS | 0.74 | 0.78 | 0.59 | 0.96 |
| Actual EPS | 0.8 | 1.01 | 0.67 | 1.21 |
| Difference | 0.06 | 0.23 | 0.08 | 0.25 |
| Surprise % | 8.10% | 29.50% | 13.60% | 26.00% |
| EPS trend | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| Current estimate | 0.98 | 1.06 | 4.08 | 4.43 |
| 7 days ago | 1.02 | 1.01 | 3.96 | 4.39 |
| 30 days ago | 1.02 | 0.96 | 3.96 | 4.39 |
| 60 days ago | 0.89 | 1.01 | 3.98 | 4.41 |
| 90 days ago | 0.88 | 0 | 4.04 | 4.37 |
| EPS revisions | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| Up last 7 days | N/A | 1 | 1 | 1 |
| Up last 30 days | N/A | 2 | 1 | 1 |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | 1 | N/A | N/A | N/A |
| Growth estimates | BIOG-B.ST | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | 22.50% | N/A | N/A | N/A |
| Next qtr. | 5.00% | N/A | N/A | N/A |
| Current year | 12.70% | N/A | N/A | N/A |
| Next year | 8.60% | N/A | N/A | N/A |
| Next 5 years (per annum) | 16.50% | N/A | N/A | N/A |
| Past 5 years (per annum) | 18.87% | N/A | N/A | N/A |
